Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ: ILMN )

76.77 -0.84 (-1.08%)
Streaming Delayed Price Updated: 11:03 AM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
31 32 Next >
Illuminating Rare Disease: Get to Know SLC6A1 Connect
SOURCE: Illumina 
Via 3BL Media
Illumina Partners With Centers Across France to Advance a Precision Medicine Approach for Patients With Late-Stage Cancer
SOURCE: Illumina 
Via 3BL Media
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big... 
Via Benzinga
Analyst Ratings For Illumina
Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following ... 
Via Benzinga
How Far Can the Stock Market Fall?
The stock market as measured by the S&P 500 has been correcting since the start of the new year. Most of the damage has come from the significantly overvalued constituents. 
Via Talk Markets
Illumina Collaborates With National Cancer Center Japan to Address a Leading Cause of Death in Asia
SOURCE: Illumina 
Via 3BL Media
Illumina Earns Gold Class in the S&P Global's 2022 Sustainability Yearbook
SOURCE: Illumina 
Via 3BL Media
Topics Stocks
Exposures US Equities
Promising Results Continue to Develop Optimism in Fight Against Cancers
FN Media Group Presents USA News Group News Commentary Vancouver, BC –January 27, 2021 – USA News Group – There’s plenty of optimism surrounding the major medical breakthroughs targeting multiple types... 
Via FinancialNewsMedia
Illumina's Diversity, Equity, and Inclusion Actions Earn External Recognition and Further Advance Our Culture of Care
SOURCE: Illumina 
Via 3BL Media
Panic reversal
Crude oil inventories turned out to be fuller than expected, helping reduce the oil price rise. 
Via Talk Markets
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 34 stocks hit new 52-week lows. Things to Consider About Today's 52-Week Lows: Illumina (NASDAQ:ILMN) was the biggest company... 
Via Benzinga
Illumina Grant Recipient Addresses Food Insecurities Through the Breeding of Yams
SOURCE: Illumina 
Via 3BL Media
Multiplex Assays Market worth $4.3 billion by 2026 – Key Players are Illumina, Inc. (US), Luminex Corporation (US)
Via AB Newswire
Buy Smart With Software Stocks on the Dip
With tech taking over, software stocks are inevitable winners. But when buying the dip, look for low valuation and high durability. 
Via InvestorPlace
Illumina Collaborates With Nashville Biosciences to Accelerate Medicines Development
SOURCE: Illumina 
Via 3BL Media
Illumina's Nonprofit Partner Future Kings Is Cultivating the Next Generation of STEM Leaders
SOURCE: Illumina 
Via 3BL Media
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
Upgrades Canaccord Genuity upgraded the previous rating for Fortuna Silver Mines Inc (NYSE: 
Via Benzinga
Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership
SOURCE: Illumina 
Via 3BL Media
Will Earnings Extend The Rally In Value Stocks?
US stocks extended their decline from the first week of 2022. Bank earnings disappointed investors. Inflation remained high. Investors questioned the strength of the economy to get through the omicron... 
Via Talk Markets
Illumina Named One of America's Most JUST Companies for Third Consecutive Year
SOURCE: Illumina 
Via 3BL Media
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
If You Invested $1,000 When Illumina Acquired Solexa, Here's How Much You'd Have Now
Genome sequencing company Illumina Inc (NASDAQ: ILMN) has transformed its business over the years with a handful of acquisitions and new product launches. An acquisition in 2006... 
Via Benzinga
Promising Developments in Breast Cancer Treatments Ahead in 2022
FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 12, 2022 – USA News Group – So far in 2022, there have already been some impressive developments in the battle against... 
Via FinancialNewsMedia
Benzinga's Top Ratings Upgrades, Downgrades For January 12, 2022
Upgrades Citigroup upgraded the previous rating for Solo Brands Inc (NYSE: 
Via Benzinga
Illumina Partners With Agendia to Expand Genomic Testing in Breast Cancer Care
SOURCE: Illumina 
Via 3BL Media
48 Biggest Movers From Yesterday
Gainers Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT... 
Via Benzinga
Illumina Jumps As Gene Sequencing Demand Drives Stronger Outlook
Piper says Pacific Bio has a new competitor in Illumina amid plans to launch what looks like a consumable allowing long-read sequencing on its analyzers. 
Via Talk Markets
30 Stocks Moving In Tuesday's Mid-Day Session
Gainers TSR, Inc. (NASDAQ: TSRI) shares climbed 36.6% to $12.21 following Q2 results. The company reported Q2 revenue of $23.9 million, versus $16.1 million year over year.... 
Via Benzinga
Illumina Announces New Innovative Partnerships, Along With New Groundbreaking Technologies at 2022 J.P. Morgan Healthcare Conference
SOURCE: Illumina 
Via 3BL Media
$100 Invested In This Stock 5 Years Ago, Would Be Worth This Much
Illumina (NASDAQ:ILMN) has outperformed the market over the past 5 years by 3.83% on an annualized basis. Buying $100 In ILMN: 5 years ago, an investor could have purchased 0.62... 
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.